CFDE Data Portal | Search SLC1A2

	Label	Description
	SLC1A2 associations Collection (Entity type)	Associations for SLC1A2_associations
	SLC1A2 Down Gene Set (Entity type)	A Gene Set from LINCS
	SLC1A2 Up Gene Set (Entity type)	A Gene Set from LINCS
	SLC1A2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SLC1A2 Gene (Entity type)	ENSG00000110436 - solute carrier family 1 member 2
	GSE220806 progesterone fibroblast 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226285 3 V 0 GLUTATHIONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165960 MEK inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273,GSE216292 14 V 1 PALBOCICLIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

SLC1A2 associations

Associations for SLC1A2_associations

SLC1A2 Down

A Gene Set from LINCS

SLC1A2 Up

A Gene Set from LINCS

SLC1A2 associations.tsv

A file from IDG as part of the Harmonizome project

SLC1A2

ENSG00000110436 - solute carrier family 1 member 2

GSE220806 progesterone fibroblast 1 v 3 human dn

A Gene Set from LINCS

GSE226285 3 V 0 GLUTATHIONE HUMAN UP

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 5 human dn

A Gene Set from LINCS

GSE165960 MEK inhibition 0 v 1 human dn

A Gene Set from LINCS

GSE216273,GSE216292 14 V 1 PALBOCICLIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.